<table>
  <tr>
    <th>代码</th>
    <th>公司</th>
    <th>股价(元)</th>
    <th colspan="3">归母净利润同比增速</th>
    <th colspan="3">EPS(元)</th>
    <th colspan="3">PE(倍)</th>
    <th>投资评级</th>
  </tr>
  <tr>
    <th></th>
    <th></th>
    <th></th>
    <th>2022E</th>
    <th>2023E</th>
    <th>2024E</th>
    <th>2022E</th>
    <th>2023E</th>
    <th>2024E</th>
    <th>2022E</th>
    <th>2023E</th>
    <th>2024E</th>
    <th></th>
  </tr>
  <tr>
    <td>6078.HK</td>
    <td>海吉亚医疗</td>
    <td>58.7</td>
    <td>44%</td>
    <td>61%</td>
    <td>5%</td>
    <td>0.98</td>
    <td>1.58</td>
    <td>1.65</td>
    <td>60</td>
    <td>37</td>
    <td>35</td>
    <td>买入</td>
  </tr>
  <tr>
    <td>1951.HK</td>
    <td>锦欣生殖</td>
    <td>6.6</td>
    <td>32%</td>
    <td>31%</td>
    <td>27%</td>
    <td>0.18</td>
    <td>0.24</td>
    <td>0.3</td>
    <td>36</td>
    <td>28</td>
    <td>22</td>
    <td>买入</td>
  </tr>
  <tr>
    <td>2500.HK</td>
    <td>启明医疗-B</td>
    <td>14.7</td>
    <td>-7%</td>
    <td>37%</td>
    <td>5%</td>
    <td>-0.91</td>
    <td>-0.57</td>
    <td>-0.54</td>
    <td>-</td>
    <td>-</td>
    <td>-</td>
    <td>买入</td>
  </tr>
  <tr>
    <td>2269.HK</td>
    <td>药明生物</td>
    <td>64.6</td>
    <td>45%</td>
    <td>38%</td>
    <td>35%</td>
    <td>1.17</td>
    <td>1.6</td>
    <td>2.16</td>
    <td>55</td>
    <td>40</td>
    <td>30</td>
    <td>-</td>
  </tr>
  <tr>
    <td>1877.HK</td>
    <td>君实生物</td>
    <td>34.8</td>
    <td>-56%</td>
    <td>29%</td>
    <td>12%</td>
    <td>-1.14</td>
    <td>-0.81</td>
    <td>-0.71</td>
    <td>-</td>
    <td>-</td>
    <td>-</td>
    <td>买入</td>
  </tr>
  <tr>
    <td>600276.SH</td>
    <td>恒瑞医药</td>
    <td>43.6</td>
    <td>2%</td>
    <td>18%</td>
    <td>18%</td>
    <td>0.72</td>
    <td>0.85</td>
    <td>1.01</td>
    <td>60</td>
    <td>51</td>
    <td>43</td>
    <td>买入</td>
  </tr>
  <tr>
    <td>300015.SZ</td>
    <td>爱尔眼科</td>
    <td>32.6</td>
    <td>53%</td>
    <td>29%</td>
    <td>29%</td>
    <td>0.49</td>
    <td>0.64</td>
    <td>0.82</td>
    <td>66</td>
    <td>51</td>
    <td>40</td>
    <td>买入</td>
  </tr>
  <tr>
    <td>300760.SZ</td>
    <td>迈瑞医疗</td>
    <td>324.2</td>
    <td>22%</td>
    <td>23%</td>
    <td>24%</td>
    <td>8.07</td>
    <td>9.92</td>
    <td>12.28</td>
    <td>40</td>
    <td>33</td>
    <td>26</td>
    <td>买入</td>
  </tr>
  <tr>
    <td>000538.SZ</td>
    <td>云南白药</td>
    <td>56.1</td>
    <td>49%</td>
    <td>15%</td>
    <td>16%</td>
    <td>2.32</td>
    <td>2.66</td>
    <td>3.08</td>
    <td>24</td>
    <td>21</td>
    <td>18</td>
    <td>买入</td>
  </tr>
  <tr>
    <td>600129.SH</td>
    <td>太极集团</td>
    <td>32.8</td>
    <td>163%</td>
    <td>84%</td>
    <td>44%</td>
    <td>0.59</td>
    <td>1.08</td>
    <td>1.55</td>
    <td>56</td>
    <td>30</td>
    <td>21</td>
    <td>买入</td>
  </tr>
  <tr>
    <td>000999.SZ</td>
    <td>华润三九</td>
    <td>47.2</td>
    <td>17%</td>
    <td>18%</td>
    <td>14%</td>
    <td>2.42</td>
    <td>2.86</td>
    <td>3.25</td>
    <td>20</td>
    <td>17</td>
    <td>15</td>
    <td>买入</td>
  </tr>
  <tr>
    <td>300357.SZ</td>
    <td>我武生物</td>
    <td>54.0</td>
    <td>21%</td>
    <td>26%</td>
    <td>28%</td>
    <td>0.78</td>
    <td>0.98</td>
    <td>1.25</td>
    <td>69</td>
    <td>55</td>
    <td>43</td>
    <td>买入</td>
  </tr>
  <tr>
    <td>300896.SZ</td>
    <td>爱美客</td>
    <td>600.0</td>
    <td>51%</td>
    <td>44%</td>
    <td>45%</td>
    <td>6.69</td>
    <td>9.66</td>
    <td>13.96</td>
    <td>90</td>
    <td>62</td>
    <td>43</td>
    <td>买入</td>
  </tr>
  <tr>
    <td>300122.SZ</td>
    <td>智飞生物</td>
    <td>94.5</td>
    <td>-29%</td>
    <td>35%</td>
    <td>18%</td>
    <td>4.55</td>
    <td>6.16</td>
    <td>7.29</td>
    <td>21</td>
    <td>15</td>
    <td>13</td>
    <td>买入</td>
  </tr>
  <tr>
    <td>600763.SH</td>
    <td>通策医疗</td>
    <td>155.0</td>
    <td>2%</td>
    <td>42%</td>
    <td>32%</td>
    <td>2.23</td>
    <td>3.17</td>
    <td>4.16</td>
    <td>69</td>
    <td>49</td>
    <td>37</td>
    <td>买入</td>
  </tr>
  <tr>
    <td>688235.SH</td>
    <td>百济神州</td>
    <td>147.3</td>
    <td>17%</td>
    <td>28%</td>
    <td>26%</td>
    <td>-6</td>
    <td>-4.32</td>
    <td>-3.18</td>
    <td>-</td>
    <td>-</td>
    <td>-</td>
    <td>-</td>
  </tr>
  <tr>
    <td>688331.SH</td>
    <td>荣昌生物</td>
    <td>82.5</td>
    <td>-168%</td>
    <td>97%</td>
    <td>9886%</td>
    <td>-0.34</td>
    <td>-0.01</td>
    <td>0.94</td>
    <td>-</td>
    <td>-</td>
    <td>76</td>
    <td>-</td>
  </tr>
  <tr>
    <td>688266.SH</td>
    <td>泽璟制药-U</td>
    <td>52.7</td>
    <td>29%</td>
    <td>78%</td>
    <td>336%</td>
    <td>-1.33</td>
    <td>-0.3</td>
    <td>0.7</td>
    <td>-</td>
    <td>-</td>
    <td>75</td>
    <td>持有</td>
  </tr>
  <tr>
    <td>688271.SH</td>
    <td>联影医疗</td>
    <td>189.8</td>
    <td>24%</td>
    <td>32%</td>
    <td>30%</td>
    <td>2.13</td>
    <td>2.8</td>
    <td>3.64</td>
    <td>89</td>
    <td>68</td>
    <td>52</td>
    <td>-</td>
  </tr>
  <tr>
    <td>688212.SH</td>
    <td>澳华内镜</td>
    <td>75.8</td>
    <td>7%</td>
    <td>62%</td>
    <td>43%</td>
    <td>0.46</td>
    <td>0.74</td>
    <td>1.06</td>
    <td>166</td>
    <td>102</td>
    <td>71</td>
    <td>-</td>
  </tr>
  <tr>
    <td>688293.SH</td>
    <td>奥浦迈</td>
    <td>115.4</td>
    <td>70%</td>
    <td>60%</td>
    <td>45%</td>
    <td>1.25</td>
    <td>2</td>
    <td>2.89</td>
    <td>92</td>
    <td>58</td>
    <td>40</td>
    <td>买入</td>
  </tr>
  <tr>
    <td>688185.SH</td>
    <td>康希诺</td>
    <td>139.1</td>
    <td>-76%</td>
    <td>105%</td>
    <td>23%</td>
    <td>1.83</td>
    <td>3.75</td>
    <td>4.62</td>
    <td>53</td>
    <td>26</td>
    <td>21</td>
    <td>买入</td>
  </tr>
  <tr>
    <td>688114.SH</td>
    <td>华大智造</td>
    <td>118.7</td>
    <td>318%</td>
    <td>-64%</td>
    <td>26%</td>
    <td>4.89</td>
    <td>1.74</td>
    <td>2.19</td>
    <td>24</td>
    <td>68</td>
    <td>54</td>
    <td>买入</td>
  </tr>
  <tr>
    <td>688105.SH</td>
    <td>诺唯赞</td>
    <td>59.2</td>
    <td>34%</td>
    <td>9%</td>
    <td>20%</td>
    <td>2.27</td>
    <td>2.47</td>
    <td>2.95</td>
    <td>26</td>
    <td>24</td>
    <td>20</td>
    <td>买入</td>
  </tr>
  <tr>
    <td>688050.SH</td>
    <td>爱博医疗</td>
    <td>230.3</td>
    <td>42%</td>
    <td>38%</td>
    <td>39%</td>
    <td>2.3</td>
    <td>3.18</td>
    <td>4.41</td>
    <td>100</td>
    <td>73</td>
    <td>52</td>
    <td>买入</td>
  </tr>
</table>

数据来源：Wind，西南证券

1.2 上周弹性组合分析

迈得医疗(688310)：22H1业绩符合预期，血液透析类产品贡献主要增量
寿仙谷(603896)：疫情短期影响有限，看好省外扩张
祥生医疗(688358.SH)：三季度业绩延续高增长，高端产品持续放量
上海医药(601607)：三季度业绩符合预期，创新驱动加速转型
福瑞股份(300049)：业绩符合预期，22Q3同比高增长
贝达药业(300558)：多重因素短期影响业绩，创新管线持续推进
三诺生物(300298.SZ)：业绩增长超预期，CGM获批在即
美好医疗(301363.SZ)：家用呼吸机组件龙头，平台化渐成